Sterling Biotech reports standalone net loss of Rs 116.72 crore in the September 2014 quarter

Sales rise 7.07% to Rs 172.75 crore

Net Loss of Sterling Biotech reported to Rs 116.72 crore in the quarter ended September 2014 as against net loss of Rs 99.38 crore during the previous quarter ended September 2013. Sales rose 7.07% to Rs 172.75 crore in the quarter ended September 2014 as against Rs 161.35 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales172.75161.35 7 OPM %12.8916.87 -PBDT-106.32-83.76 -27 PBT-170.14-147.11 -16 NP-116.72-99.38 -17

Powered by Capital Market - Live News